Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Independence of measles-specific humoral and cellular immune responses to vaccination.

Jacobson RM, Ovsyannikova IG, Vierkant RA, Pankratz VS, Poland GA.

Hum Immunol. 2012 May;73(5):474-9. doi: 10.1016/j.humimm.2012.02.016. Epub 2012 Mar 3.

2.

Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.

Umlauf BJ, Haralambieva IH, Ovsyannikova IG, Kennedy RB, Pankratz VS, Jacobson RM, Poland GA.

Viral Immunol. 2012 Feb;25(1):29-36. doi: 10.1089/vim.2011.0051. Epub 2012 Jan 12.

3.

Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.

Dhiman N, Ovsyannikova IG, Ryan JE, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA.

Clin Exp Immunol. 2005 Dec;142(3):498-504.

4.

Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years.

Njie-Jobe J, Nyamweya S, Miles DJ, van der Sande M, Zaman S, Touray E, Hossin S, Adetifa J, Palmero M, Burl S, Jeffries D, Rowland-Jones S, Flanagan K, Jaye A, Whittle H.

Vaccine. 2012 Mar 28;30(15):2543-50. doi: 10.1016/j.vaccine.2012.01.083. Epub 2012 Feb 5.

5.

The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity.

Ovsyannikova IG, Haralambieva IH, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA.

Hum Genet. 2011 Oct;130(4):547-61. doi: 10.1007/s00439-011-0977-x. Epub 2011 Mar 19.

6.

A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine.

Haralambieva IH, Ovsyannikova IG, O'Byrne M, Pankratz VS, Jacobson RM, Poland GA.

Vaccine. 2011 Jun 15;29(27):4485-91. doi: 10.1016/j.vaccine.2011.04.037. Epub 2011 May 1.

7.

Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.

Wong-Chew RM, Beeler JA, Audet S, Santos JI.

J Med Virol. 2003 Jun;70(2):276-80.

PMID:
12696117
8.

Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age.

Gans HA, Yasukawa LL, Sung P, Sullivan B, DeHovitz R, Audet S, Beeler J, Arvin AM.

J Infect Dis. 2013 Feb 15;207(4):574-82. doi: 10.1093/infdis/jis719. Epub 2013 Jan 8.

9.

Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

Ovsyannikova IG, Dhiman N, Jacobson RM, Vierkant RA, Poland GA.

Clin Diagn Lab Immunol. 2003 May;10(3):411-6.

10.

Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.

Haralambieva IH, Ovsyannikova IG, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA.

Vaccine. 2011 Oct 19;29(45):7883-95. doi: 10.1016/j.vaccine.2011.08.083. Epub 2011 Aug 27.

11.

A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants.

García-León ML, Bonifaz LC, Espinosa-Torres B, Hernández-Pérez B, Cardiel-Marmolejo L, Santos-Preciado JI, Wong-Chew RM.

Hum Vaccin Immunother. 2015;11(7):1762-9. doi: 10.1080/21645515.2015.1032488.

12.

Measles immunity and response to revaccination among secondary school children in Cumbria.

Calvert N, Cutts F, Irving R, Brown D, Marsh J, Miller E.

Epidemiol Infect. 1996 Feb;116(1):65-70.

13.

Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose.

Jacobson RM, Ovsyannikova IG, Vierkant RA, Pankratz VS, Poland GA.

Vaccine. 2011 Oct 19;29(45):7982-91. doi: 10.1016/j.vaccine.2011.08.060. Epub 2011 Aug 26.

14.

Vaccine-induced measles virus-specific T cells do not prevent infection or disease but facilitate subsequent clearance of viral RNA.

Lin WH, Pan CH, Adams RJ, Laube BL, Griffin DE.

MBio. 2014 Apr 15;5(2):e01047. doi: 10.1128/mBio.01047-14.

15.

Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.

Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.

Vaccine. 2006 Jan 30;24(5):683-90. Epub 2005 Aug 24.

PMID:
16154241
16.

Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes.

White SJ, Haralambieva IH, Ovsyannikova IG, Vierkant RA, O'Byrne MM, Poland GA.

Hum Immunol. 2012 Jun;73(6):636-40. doi: 10.1016/j.humimm.2012.03.015. Epub 2012 Apr 12.

17.

Induction of cytokine mRNA in peripheral blood mononuclear cells of infants after the first dose of measles vaccine.

Li H, Hickman CJ, Helfand RF, Keyserling H, Anderson LJ, Bellini WJ.

Vaccine. 2001 Sep 14;19(32):4896-900.

PMID:
11535343
18.

Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts.

Lambert ND, Haralambieva IH, Ovsyannikova IG, Larrabee BR, Pankratz VS, Poland GA.

Immunol Res. 2014 Jan;58(1):1-8. doi: 10.1007/s12026-013-8475-y.

19.

Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.

Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM.

J Infect Dis. 2004 Jul 1;190(1):83-90. Epub 2004 May 26.

PMID:
15195246
20.

Supplemental Content

Support Center